Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the european prospective investigation into cancer and nutrition

American Journal of Epidemiology

Volumn 172, Issue 12, 2010, Pages 1384-1393

  Duell, Eric J ^a   Travier, Noémie ^a   Leila, Lujan Barroso ^a   Boutron Ruault, M C ^a   Clavel Chapelon, F ^a   Palli, Domenico ^a   Krogh, Vittorio ^a   Mattiello, Amalia ^a   Tumino, Rosario ^a   Sacerdote, Carlotta ^a   Rodriguez, Laudina ^a   Emilio, Sanchez Cantalejo ^a   Navarro, Carmen ^a   Barricarte, Aurelio ^a   Dorronsoro, Miren ^a   Khaw, Kay Tee ^a   Wareham, Nicholas ^a   Allen, Naomi E ^a   Tsilidis, Konstantinos K ^a   Bas, H Bueno De Mesquita ^a   Jeurnink, Suzanne M ^a   Numans, M E ^a   Peeters, Petra H M ^a   Lagiou, Pagona ^a   Valanou, Elisabeth ^a   Trichopoulou, Antonia ^a   Kaaks, Rudolf ^a   Annekatrin, Lukanova Mcgregor ^a   Bergman, Manuela M ^a   Boeing, Heiner ^a   Manjer, Jonas ^a   Lindkvist, Björn ^a   Tenling, Roger ^a   Hallmans, Göran ^a   Dahm, Christina C ^a   Overvad, Kim ^a   Olsen, Anja ^a   Tjonneland, Anne ^a   Bakken, Kjersti ^a   Lund, Eiliv ^a   Jenab, Mazda ^a   McCormack, Valerie ^a   Rinaldi, Sabina ^a   Michaud, Dominique ^a   Mouw, Traci ^a   Nesi, Gabriella ^a   Carneiro, Fatima ^a   Riboli, Elio ^a   Gonzá Lez, Carlos A ^a   more..

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Estrogens; Hormones; Menstruation; Reproduction; Stomach neoplasms; Women

Indexed keywords

CANCER; CONFIDENCE INTERVAL; DISEASE INCIDENCE; DISEASE TREATMENT; ESTROGENIC COMPOUND; HYPOTHESIS TESTING; NUTRITION; REPRODUCTIVE BIOLOGY; RISK FACTOR; SEX HORMONE; TUMOR; WOMENS HEALTH;

ADULT; AGED; BODY MASS; CANCER RISK; COHORT ANALYSIS; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; NUTRITION; OVARIECTOMY; PROSPECTIVE STUDY; REPRODUCTION; REVIEW; STOMACH CANCER; ADENOCARCINOMA; AGE; ARTICLE; ESTROGEN THERAPY; EUROPE; INCIDENCE; MENARCHE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; REPRODUCTIVE HISTORY; RISK FACTOR; STOMACH TUMOR;

EUROPE;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; EUROPE; FEMALE; HUMANS; INCIDENCE; MENARCHE; MENSTRUAL CYCLE; MIDDLE AGED; OVARIECTOMY; PROPORTIONAL HAZARDS MODELS; REPRODUCTIVE HISTORY; RISK FACTORS; STOMACH NEOPLASMS;

EID: 79952117656     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq321     Document Type: Review

References (38)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108
2. Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008;44(16): 2397-2403
3. Chandanos E, Lindblad M, Rubio CA, et al. Tamoxifen exposure in relation to gastric adenocarcinoma development. Eur J Cancer. 2008;44(7):1007-1014
4. Lindblad M, YeW, Rubio C, et al. Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2203-2207
5. Matsuyama Y, Tominaga T, Nomura Y, et al. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann Oncol. 2000;11(12):1537-1543
6. Chandanos E, Rubio CA, Lindblad M, et al. Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma. Gastric Cancer. 2008;11(3):168-174
7. Fernandez E, Gallus S, Bosetti C, et al. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer. 2003;105(3):408-412
8. Frise S, Kreiger N, Gallinger S, et al. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the Canadian National Enhanced Cancer Surveillance System. Ann Epidemiol. 2006;16(12): 908-916
9. Inoue M, Ito LS, Tajima K, et al. Height, weight, menstrual and reproductive factors and risk of gastric cancer among Japanese postmenopausal women: analysis by subsite and histologic subtype. Int J Cancer. 2002;97(6):833-838
10. Kaneko S, Tamakoshi A, Ohno Y, et al. Menstrual and reproductive factors and the mortality risk of gastric cancer in Japanese menopausal females. Cancer Causes Control. 2003;14(1):53-59
11. La Vecchia C, Negri E, Franceschi S, et al. Long-term impact of reproductive factors on cancer risk. Int J Cancer. 1993;53(2): 215-219
12. La Vecchia C, D'Avanzo B, Franceschi S, et al. Menstrual and reproductive factors and gastric-cancer risk in women. Int J Cancer. 1994;59(6):761-764
13. Lindblad M, Garc?́a Rodr?́guez LA, Chandanos E, et al. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer. 2006;94(1):136-141
14. Palli D, Cipriani F, Decarli A, et al. Reproductive history and gastric cancer among post-menopausal women. Int J Cancer. 1994;56(6):812-815
15. Dorjgochoo T, Shu XO, Li HL, et al. Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer. 2009;124(10):2442-2449
16. Freedman ND, Chow WH, Gao YT, et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut. 2007;56(12):1671-1677
17. Heuch I, Kvåle G. Menstrual and reproductive factors and risk of gastric cancer: a Norwegian cohort study. Cancer Causes Control. 2000;11(9):869-874
18. Heuch I, Kvåle G. Does breastfeeding affect the risk of gastric cancer? Int J Cancer. 2003;106(6):982-983
19. Persson C, Inoue M, Sasazuki S, et al. Female reproductive factors and the risk of gastric cancer in a large-scale population-based cohort study in Japan (JPHC study). Eur J Cancer Prev. 2008;17(4):345-353
20. Freedman ND, Lacey JV Jr, Hollenbeck AR, et al. The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer. 2010;116(6):1572-1581
21. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B): 1113-1124
22. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49
23. Carneiro F, Moutinho C, Pera G, et al. Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scand J Gastroenterol. 2007;42(5):618-627
24. Palli D, Masala G, Del Giudice G, et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPICEURGAST study. Int J Cancer. 2007;120(4):859-867
25. Willett WC. Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press; 1998
26. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 2003;6(4):407-413
27. Cappola AR, Ratcliffe SJ, Bhasin S, et al. Determinants of serum total and free testosterone levels in women over the age of 65 years. J Clin Endocrinol Metab. 2007;92(2): 509-516
28. Davison SL, Bell R, Donath S, et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847-3853
29. Fogle RH, Stanczyk FZ, Zhang X, et al. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab. 2007;92(8):3040-3043
30. Judd HL, Lucas WE, Yen SS. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 1974;118(6): 793-798
31. McTiernan A, Wu L, Barnabei VM, et al. Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women. Breast Cancer Res Treat. 2008;108(2):217-231
32. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab. 1976;42(2):247-253
33. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol. 2003;4(9):721-732
34. Shi SQ, Cai JT, Yang JM. Expression of trefoil factors 1 and 2 in precancerous condition and gastric cancer. World J Gastroenterol. 2006;12(19):3119-3122
35. Campbell-Thompson ML. Estrogen receptor alpha and beta expression in upper gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats. Biochem Biophys Res Commun. 1997;240(2):478-483
36. Katoh M. Trefoil factors and human gastric cancer (review). Int J Mol Med. 2003;12(1):3-9
37. Oshima CT, Wonraht DR, Catarino RM, et al. Estrogen and progesterone receptors in gastric and colorectal cancer. Hepatogastroenterology. 1999;46(30):3155-3158
38. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1998